University Hospital Sagrat Cor
- Address
- Londres Street 28, 08029 Barcelona, Spain
University Hospital Sagrat Cor - Anticoagulation Management Research
University Hospital Sagrat Cor specializes in clinical research focused on perioperative bleeding management and anticoagulation therapy. The center demonstrates particular expertise in oral and maxillofacial surgical procedures for patients on complex anticoagulation regimens, contributing valuable evidence to improve safety outcomes in dental surgery.
- Prevention of postoperative bleeding in anticoagulated patients
- Tranexamic acid applications in oral surgery
- Management of patients on direct oral anticoagulants (DOACs) and vitamin K antagonists
The hospital's research program addresses critical clinical challenges in managing patients requiring tooth extractions while on anticoagulation therapy. By investigating prophylactic interventions such as topical hemostatic agents, the center aims to reduce clinically relevant bleeding events and orofacial hematomas, ultimately improving safety protocols for high-risk surgical patients in dental and oral surgery settings.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
- 1Hyloris Developments1active
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 567 other sites in Spain
Therapeutic Area Benchmark — Spain
Select a therapeutic area to compare against other sites in Spain.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Spain
Market Share
Country: Spain
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in University Hospital Sagrat Cor
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Prospective, Open-Label, Randomized, Interventional Study to Evaluate the Efficacy and Tolerability of Sucrosomial® Iron vs Ferric Maltol in Iron Deficient Women | Pharmanutra S.p.A. | Phase I | Recruiting | Dec 2025 | — |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Tranexamic Acid | 1 | Unknown | 2024-05-06 | 2024-05-06 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.